Skip to main content
. 2020 Jun 23;11(17):5042–5055. doi: 10.7150/jca.45553

Table 1.

The association between UQCRC2 and clinicopathological factors in 105 GC patients in the TMA validation cohort (n=105)

Clinicopathological factors Number (n=105) Relative expression P value
Low (n=74) High (n=31)
Gender 0.608
Male 58 39 19
Female 47 35 12
Age 0.616
≤ 60 43 28 15
> 60 62 46 16
Size (cm) 0.211
≤ 5 41 36 5
> 5 64 38 26
TNM stage 0.009
I, II 59 32 27
III, IV 46 42 4
Lymphatic metastasis 0.004
NO 81 58 23
YES 24 16 8
Distant metastasis 0.013
NO 75 51 24
YES 30 23 7
Recurrence 0.051
NO 79 53 26
YES 26 21 5

High and low expression of UQCRC2 protein was defined according to the cut-off value of 4 for immunoreactivity score (IS).